News / Business
Therapeutics Based on Human Cells and their Derivatives from Biotechnology Company Proteonomix, Inc., a Featured Client on SmallCapVoice
SmallCapVoice is currently highlighting Proteonomix, Inc. (OTCPK: PROT) as a Featured Client on SmallCapVoice.com. Current shareholders and potential investors of PROT have access to the latest stock prices, a review of stock performance, detailed charts and graphs, a complete list of filings, and the most recent press releases distributed by Proteonomix, Inc.
Proteonomix, Inc. is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. The Company is developing an intellectual property portfolio in the areas of therapeutics and cosmetics. Its research and development program has demonstrated results with more than ten patent applications and multiple products ready to enter their respective markets. The Company has facilities at a number of academic institutions.
To view a list of SmallCapVoice Featured Clients please go to: http://www.smallcapvoice.com/Small-Cap-OTC-Stock-Companies.html
SmallCapVoice provides comprehensive Investor Relations and Financial Relations packages designed to effectively brand and distribute information about each client company.
With a full menu of services ranging from audio interviews and a daily newsletter to securing financial and corporate financing solutions, SmallCapVoice knows what it takes to keep a company’s presence in the investor community visible.
For more information about how your company can become a Featured Client on SmallCapVoice please go to:
http://www.smallcapvoice.com/Investor-Relation-Services.html
SmallCapVoice is dedicated to ensuring its client companies gain valuable exposure in the small cap and OTC markets. Through internet interviews, conference calls, emails, investor newsletters, inclusion in the investment newsletter “The Small Cap Daily” and, placement on financial web sites SmallCapVoice creates a consistent presence in the public eye for their clients.
Contact:
Stuart T. Smith
CEO
512-267-2430
